                         SEQUENCE LISTING

<110>  The Board of Trustees of the University of Alabama
 
<120>  Methods for Increasing Insulin Sensitivity and Treating Diabetes 
       with a Bioactive Chromium Binding Peptide

<130>  10025-069WO1

<150>  61/656,652
<151>  2012-06-07

<160>  42    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  1

Xaa Glu Glu Glu Glu Gly Asp Asp 
1               5               


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  2

Xaa Glu Glu Glu Gly Glu Asp Asp 
1               5               


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3

Glu Glu Glu Glu Gly Asp Asp 
1               5           


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  amino acid with a carboxylate side chain or an amino acid with a 
       side chain that can be converted to a carboxylate side chain

<220>
<221>  MISC_FEATURE
<222>  (6)..(7)
<223>  amino acid with a carboxylate side chain or an amino acid with a 
       side chain that can be converted to a carboxylate side chain

<400>  4

Xaa Xaa Xaa Xaa Gly Xaa Xaa 
1               5           


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  5

Glu Glu Glu Glu Gly Asn Asn 
1               5           


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  6

Glu Glu Glu Glu Gly Asp Asn 
1               5           


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  7

Glu Glu Glu Glu Gly Asn Asp 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  8

Gln Glu Glu Glu Gly Asp Asp 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  9

Glu Gln Glu Glu Gly Asp Asp 
1               5           


<210>  10
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  10

Glu Glu Gln Glu Gly Asp Asp 
1               5           


<210>  11
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  11

Glu Glu Glu Gln Gly Asp Asp 
1               5           


<210>  12
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  12

Gln Gln Glu Glu Gly Asp Asp 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  13

Gln Glu Glu Gln Gly Asp Asp 
1               5           


<210>  14
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  14

Glu Gln Gln Glu Gly Asp Asp 
1               5           


<210>  15
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  15

Glu Gln Glu Gln Gly Asp Asp 
1               5           


<210>  16
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  16

Glu Glu Gln Gln Gly Asp Asp 
1               5           


<210>  17
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  17

Gln Gln Gln Glu Gly Asp Asp 
1               5           


<210>  18
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  18

Glu Gln Gln Gln Gly Asp Asp 
1               5           


<210>  19
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  19

Xaa Glu Glu Glu Glu Gly Asn Asn 
1               5               


<210>  20
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  20

Xaa Glu Glu Glu Glu Gly Asp Asn 
1               5               


<210>  21
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  21

Xaa Glu Glu Glu Glu Gly Asn Asp 
1               5               


<210>  22
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  22

Xaa Gln Glu Glu Glu Gly Asp Asp 
1               5               


<210>  23
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  23

Xaa Glu Gln Glu Glu Gly Asp Asp 
1               5               


<210>  24
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  24

Xaa Glu Glu Gln Glu Gly Asp Asp 
1               5               


<210>  25
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  25

Xaa Glu Glu Glu Gln Gly Asp Asp 
1               5               


<210>  26
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  26

Pro Gln Gln Glu Glu Gly Asp Asp 
1               5               


<210>  27
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  27

Xaa Gln Glu Glu Gln Gly Asp Asp 
1               5               


<210>  28
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  28

Xaa Glu Gln Gln Glu Gly Asp Asp 
1               5               


<210>  29
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  29

Xaa Glu Gln Glu Gln Gly Asp Asp 
1               5               


<210>  30
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  30

Xaa Glu Glu Gln Gln Gly Asp Asp 
1               5               


<210>  31
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  31

Xaa Gln Gln Gln Glu Gly Asp Asp 
1               5               


<210>  32
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  32

Xaa Glu Gln Gln Gln Gly Asp Asp 
1               5               


<210>  33
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  33

Asp Glu Glu Glu Gly Asp Glu 
1               5           


<210>  34
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  34

Glu Asp Glu Glu Gly Asp Glu 
1               5           


<210>  35
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  35

Glu Glu Asp Glu Gly Asp Glu 
1               5           


<210>  36
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  36

Glu Glu Glu Asp Gly Asp Glu 
1               5           


<210>  37
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  37

Asp Glu Glu Glu Gly Glu Asp 
1               5           


<210>  38
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  38

Glu Asp Glu Glu Gly Glu Asp 
1               5           


<210>  39
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  39

Glu Glu Asp Glu Gly Glu Asp 
1               5           


<210>  40
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  40

Glu Glu Glu Asp Gly Glu Asp 
1               5           


<210>  41
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  41

Glu Asp Gly Glu Glu Cys Asp Cys Gly Glu 
1               5                   10  


<210>  42
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  42

Asp Gly Glu Glu Cys Asp Cys Gly Glu Glu 
1               5                   10  


